MB "IVB Pharma Consulting" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
Financial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
243,928 |
120,162 |
80,113 |
76,079 |
37,477 |
70.60 |
31.19 |
132,394 |
23,226 |
0 |
155,620 |
2022 |
---|
247,936 |
122,741 |
84,649 |
80,275 |
39,740 |
85.63 |
32.38 |
145,620 |
41,662 |
17,171 |
170,111 |
2023 |
---|
223,245 |
212,614 |
100,459 |
95,927 |
91,359 |
75.62 |
42.97 |
183,659 |
16,590 |
0 |
200,249 |
Register and
explore Okredo data2023 |
---|
223,245 |
212,614 |
100,459 |
95,927 |
91,359 |
75.62 |
42.97 |
183,659 |
16,590 |
0 |
200,249 |
Register and
explore Okredo data2023
Turnover (€)
223,245 €-10 % *
Sales per employee (€)
212,614 €73 % *
Profit before tax (€)
100,459 €19 % *
Net Profit (€)
95,927 €20 % *
Profit per employee (€)
91,359 €130 % *
Total profitability (%)
75.62 %-11.69 % *
Net profitability (%)
42.97 %32.71 % *
Equity (€)
183,659 €26 % *
Amounts Payable And Liabilities (€)
16,590 €-60 % *
Non-current Assets (€)
0 €-100 % *
CurrentAssets (€)
200,249 €18 % *